NCT06862713Completed
Effects of Walking and Home-Based Pulmonary Rehabilitation on Anxiety and Sleep Quality
Determination of the Effects of Walking and Home-Based Pulmonary Rehabilitation on Anxiety and Sleep Quality in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 15 Apr 2025
Brief summary (registry, in English)
Although pulmonary rehabilitation plays an important role in increasing exercise tolerance and reducing hospitalizations in patients with chronic obstructive pulmonary disease (COPD), adherence to treatment is often low. Therefore, home-based pulmonary rehabilitation (PR) programs stand out as an effective intervention to alleviate the physiological and psychological burden of COPD patients and improve their quality of life. Nursing should develop a holistic approach to addressing the physical and psychological needs of patients to enhance the effectiveness of these programs. This study aims to evaluate the effects of an 8-week home-based PR program on cardiopulmonary parameters, respiratory function, anxiety levels, and sleep quality in COPD patients. As a randomized controlled trial, COPD patients will be divided into experimental and control groups. Pre- and post-tests will include the 6-minute walking test (6 MWT), dyspnea score, oxygen saturation, respiratory function tests (FEV1, FVC, FEV1/FVC, FEF 25-75), anxiety (STAI-I and STAI-II), and sleep quality (PSQI). Post-tests will be collected after the eight-week intervention.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 90 (actual)
- First submitted
- 11 Feb 2025
- Start date
- 1 Apr 2024
- Primary completion date
- 1 Mar 2025
- Lead sponsor
- Bilecik Seyh Edebali Universitesi
- Diseases
- COPD
- NCT number
- NCT06862713
What you commit to
- Study type: Interventional
- Participants enrolled: 90
- From 1 Apr 2024 to the primary completion date, 1 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving continuous oxygen therapy
Other illness
- Patients with a history of pulmonary hypertension, malignancy, pulmonary thromboembolism, obstructive sleep apnea, unstable angina, or myocardial infarction
- Patients with a heart rate above 120/min
Other
- Patients who require hospitalization after starting the study
Who the study is looking for
- Age ≥ 18 years
- Ability to speak and understand Turkish
- Baseline saturation \> 85%
- Confirmed stage II or stage III COPD diagnosis according to GOLD guidelines
- No infection or COPD exacerbation in the last 3 months
- Not participating in a pulmonary rehabilitation program in the last 3 months
- Able to walk without assistance and lift weights up to 2 kg
- No history of serious and/or unstable heart disease, neuromuscular disease, orthopedic disease, or mental illness that may affect daily physical activities
- Agree to participate in the study and give written informed consent
- No communication problems
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gulhane Education and Research Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.